ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 776

Tumor Necrosis Factor Alpha Modifies Chromatin Landscape and Amplifies Inflammatory Responses To Subsequent Stimuli In Synovial Fibroblasts

Angela Lee1, Lionel B. Ivashkiv2 and George D. Kalliolias1, 1Medicine, Hospital for Special Surgery, New York, NY, 2Arthritis and Tissue Degeneration Program and the David Z. Rosensweig Genomics Research Center, Hospital for Special Surgery, New York, NY

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Epigenetics, Fibroblasts, Rheumatoid arthritis (RA), transcriptional regulation and tumor necrosis factor (TNF)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Cytokines, Mediators, Cell-cell Adhesion, Cell Trafficking and Angiogenesis I: Identifying Novel Factors that Facilitate Neovascularization and Cell Trafficking

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Fibroblast-like synoviocytes (FLS) cross-talk with macrophages (Mf) during the course of rheumatoid arthritis (RA). Our group has shown that TNFa, primarily Mf-derived within synovium, induces chromatin modifications and a sustained inflammatory program in FLS. Here we test the hypothesis that chronic TNFa modifies the chromatin landscape in FLS, amplifying responses to subsequent inflammatory stimuli.

Methods:

FLS obtained from synovial tissues of patients with RA were chronically exposed to TNFa, then stimulated with interferons (IFNb or IFNg) and were assayed for gene expression by qPCR. NFkB signaling and chromatin modifications were evaluated using western blotting and ChIP assay.

Results:

Chronic exposure (72h) of FLS to TNFa leads to super-induction of CXCL10, CXCL11 and CXCL9 upon subsequent stimulation with IFNb or IFNg (Figure 1A). Notably, these genes reside proximally within the same locus on chromosome 4. These chemokines have been linked to RA pathogenesis and a monoclonal antibody against CXCL10 has shown promising results in a clinical trial. The expression of other classic IFN-target genes upon IFN stimulation is not affected by pre-exposure to TNF (Figure 1B and data not shown), suggesting that the effect of TNF on the IFN-inducible transcriptional program in FLS is gene-specific. After 72h of TNF stimulation, FLS were washed to remove TNF and treated with infliximab (IFX) for 24h to neutralize any residual TNF in the system and then stimulated with IFN. Despite the abrogation of TNF signaling for 24h, the super-induction of CXCL10, CXCL11 and CXCL9 was retained (Figure 1C), suggesting that TNF has a sustained impact on FLS. In addition, it was observed that chronic TNF stimulation (72h) induces histone depletion, hyperacetylation of residual histones and induction of the active histone mark H3K27Ac at the CXCL10 promoter (Figure 2A). Exposure of FLS to TNFa for 72h also induced nuclear localization and binding of p65 at the CXCL10 promoter (Figure 2B) as well as expression of transcription factors STAT1, IRF1 and IRF7 (Figure 2C).

 

Conclusion:

Chronic exposure of FLS to TNFa induces sustained chromatin activation at the CXCL10 locus, allowing its super-induction upon subsequent IFN stimulation. Since this locus contains binding sites for TNFa-induced p65, STAT1 and IRFs, we will further investigate the potential implication of these transcription factors on the observed activation of chromatin in FLS.               


Disclosure:

A. Lee,
None;

L. B. Ivashkiv,
None;

G. D. Kalliolias,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/tumor-necrosis-factor-alpha-modifies-chromatin-landscape-and-amplifies-inflammatory-responses-to-subsequent-stimuli-in-synovial-fibroblasts/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology